🏄 Grow your portfolio even on vacation with InvestingPro | Summer Sale 50% OFFCLAIM SALE

Cannabist Company Holdings Inc

NEOE:CBST

United States / Healthcare / Pharmaceuticals

Overview

10Y Historical Financials

Stock Price

0.19 CAD


Key Metrics	Latest
Total Revenue	384.7 M
Adjusted EBITDA	-2.842 M
EBITDA Margin	-0.7%
Net Profit Margin	-41.0%
Total Assets	563.8 M
Total Debt	444.5 M

10Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending										Latest
(in millions)		Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	12 Months

Revenue	0	18	29	39	77	180	460	512	511	459	385
% Growth		NA	61.6%	34.8%	97.0%	131.7%	156.3%	11.2%	0.0%	-10.3%

Adjusted EBITDA	0	(4)	20	(29)	(95)	(57)	23	9	43	29	(3)
% Margin	NA	-21.3%	69.3%	-73.7%	-122.9%	-32.0%	4.9%	1.7%	8.4%	6.3%	-0.7%

Adjusted EBIT	0	(6)	16	(34)	(104)	(77)	(30)	(76)	(20)	(20)	(41)
% Margin	NA	-35.1%	55.9%	-85.6%	-134.1%	-43.0%	-6.6%	-14.8%	-3.8%	-4.4%	-10.7%

Adjusted Net Income	0	(11)	3	(40)	(101)	(89)	(73)	(195)	(102)	(104)	(158)
% Margin	NA	-59.3%	9.8%	-100.8%	-130.6%	-49.7%	-15.9%	-38.1%	-20.0%	-22.6%	-41.0%

Adjusted Basic EPS	NA	(0.92)	0.24	(0.24)	(0.48)	(0.38)	(0.22)	(0.50)	(0.25)	(0.22)	(0.32)

Supporting Calculations

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
											Original
USD	Fiscal Year Ending										Latest
(in millions)		Dec-16	Dec-17	Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	Jun-25
	FY - 9	FY - 8	FY - 7	FY - 6	FY - 5	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM

Revenue	0	18	29	39	77	180	460	512	511	459	385
% Growth	NA	NA	61.6%	34.8%	97.0%	131.7%	156.3%	11.2%	0.0%	-10.3%

Cost of Revenue	0	(1)	25	(22)	(58)	(114)	(258)	(310)	(331)	(290)	(261)
Gross Profit	0	17	54	17	20	65	202	201	180	168	124
% Revenue	NA	92.9%	184.1%	43.5%	25.4%	36.4%	43.8%	39.4%	35.2%	36.7%	32.3%

Research and Development	0	0	0	0	0	0	0	0	0	0	0
Selling and Marketing	0	(0)	(1)	(1)	(6)	(6)	(16)	(14)	(6)	(4)	(4)
General and Admin	0	(23)	(37)	(50)	(118)	(130)	(179)	(204)	(158)	(160)	(140)
Other Inc / (Exp)	0	(1)	(1)	5	3	(58)	(122)	(362)	(130)	(25)	(31)
Total Operating Exp	0	(24)	(38)	(46)	(121)	(195)	(318)	(580)	(294)	(189)	(176)

Operating Income	0	(7)	15	(29)	(101)	(129)	(116)	(379)	(114)	(20)	(52)
% Revenue	NA	-39.3%	52.6%	-74.1%	-130.3%	-72.1%	-25.3%	-74.0%	-22.3%	-4.4%	-13.4%

Interest Expense	0	(1)	(7)	(8)	1	(6)	(30)	(54)	(55)	(41)	(46)
Pre-tax Income	0	(9)	8	(37)	(100)	(136)	(147)	(433)	(169)	(62)	(98)
Earnings of Discontinued Ops.	0	0	0	0	0	0	0	0	0	0	0
Provision for Taxes	0	(2)	(5)	(3)	(2)	16	(0)	11	(5)	(43)	(69)
Net Income to Company	0	(11)	3	(40)	(101)	(120)	(147)	(421)	(174)	(105)	(167)
% Margin	NA	-59.3%	9.8%	-100.8%	-130.6%	-66.7%	-31.9%	-82.4%	-34.1%	-22.9%	-43.3%

Minority Interest in Earnings	0	2	1	1	5	24	4	5	(1)	(1)	(0)
Net Income to Stockholders	0	(9)	3	(39)	(96)	(96)	(143)	(416)	(176)	(106)	(167)

Preferred Dividends	0	0	0	0	0	0	0	0	0	0	0
Other Adj.	0	0	0	0	0	0	0	0	0	0	0

Net Income to Common	0	(9)	3	(39)	(96)	(96)	(143)	(416)	(176)	(106)	(167)
% Margin	NA	-50.7%	11.5%	-98.6%	-124.3%	-53.4%	-31.1%	-81.3%	-34.4%	-23.1%	-43.3%

As Reported
Basic EPS (Continuing Ops)	0.00	(0.78)	0.28	(0.23)	(0.46)	(0.41)	(0.42)	(1.06)	(0.44)	(0.23)	(0.35)
Diluted EPS (Continuing Ops)	0.00	(0.78)	0.27	(0.23)	(0.46)	(0.41)	(0.42)	(1.06)	(0.44)	(0.23)	(0.35)

WA Basic Shares Out.	0.00	11.66	11.82	167.60	209.99	232.58	338.75	392.57	402.78	462.50	488.25
WA Diluted Shares Out.	0.00	11.66	12.29	167.60	209.99	232.58	338.75	392.57	402.78	462.50	488.25

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	0	(9)	8	(37)	(100)	(136)	(147)	(433)	(169)	(62)	(98)
Addback: Net Interest Expense	0	1	7	8	(1)	6	30	54	55	41	46
Addback: Other Non Operating Expenses, Total	0	1	1	(5)	(3)	11	(14)	(4)	(3)	(2)	(2)
Addback: Depreciation & Amortization	0	2	4	5	9	20	53	85	63	49	38
Addback: Restructuring Charges	0	0	0	0	0	0	0	3	5	6	2
Addback: Merger / Acquisition Expenses	0	0	0	0	0	3	8	0	0	0	0
Addback: Goodwill Impairment	0	0	0	0	0	0	72	171	19	0	0
Addback: Gain (Loss) On Sale Of Invest.	0	0	0	0	0	0	0	0	0	25	32
Addback: Gain (Loss) On Sale Of Assets	0	0	0	0	0	0	0	0	6	(30)	(23)
Addback: Asset Writedown	0	0	0	0	0	2	2	169	66	2	2
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	14	76	0	0	0	0
Addback: Other Unusual Items	0	0	0	0	0	22	(58)	(37)	0	(1)	(1)
Adjusted EBITDA	0	(4)	20	(29)	(95)	(57)	23	9	43	29	(3)
% Margin	NA	-21.3%	69.3%	-73.7%	-122.9%	-32.0%	4.9%	1.7%	8.4%	6.3%	-0.7%

Adjusted EBIT	0	(6)	16	(34)	(104)	(77)	(30)	(76)	(20)	(20)	(41)
% Margin	NA	-35.1%	55.9%	-85.6%	-134.1%	-43.0%	-6.6%	-14.8%	-3.8%	-4.4%	-10.7%

Adjusted Net Income Reconciliation
Net Income to Company	0	(11)	3	(40)	(101)	(120)	(147)	(421)	(174)	(105)	(167)
Addback: Unusual Items	0	0	0	0	0	41	100	306	97	2	12
Less: Tax Benefit of Unusual Items (26%)	0	0	0	0	0	(11)	(26)	(80)	(25)	(1)	(3)
Adjusted Net Income	0	(11)	3	(40)	(101)	(89)	(73)	(195)	(102)	(104)	(158)
% Margin	NA	-59.3%	9.8%	-100.8%	-130.6%	-49.7%	-15.9%	-38.1%	-20.0%	-22.6%	-41.0%

Loading Error

Cannabist Company Holdings Inc

NEOE:CBST

United States / Healthcare / Pharmaceuticals

10Y Historical Financials